You searched for metabolic diseases - Page 58 of 64

News and Trends 11 Dec 2015

Biotech of the Week: Zealand Pharma, Biotech Success Story made in Denmark

…on 3 therapeutic areas: metabolic, gastrointestinal and cardiovascular diseases. At present, Zealand has one marketed product through a development partnership with Sanofi, Lixisenatide, a treatment of type II diabetes, along…

December 11, 2015 - 2 minutesmins - By Philip Hemme

In Depth 4 Mar 2025

The biggest biotech funding rounds in February 2025

…total. And, thanks to Abcuro’s $200 million financing round, the autoimmune diseases subsector brought in the second-largest amount of funding last month, despite there only being one round. Public biotech…

March 4, 2025 - 4 minutesmins - By Willow Shah-Neville

Best in Biotech 4 Jul 2025

14 biotech companies to know in the Boston area in 2025

…into protein, ideal for diseases caused by mutations in large genes that are hard to edit at the DNA level. Its lead candidate, ACDN‑01, is the first-ever clinical-stage RNA exon…

July 4, 2025 - 15 minutesmins - By Jules Adam

In Depth 11 Aug 2022

Biosecurity is synthetic biology’s most crucial ally

…at Ginkgo Bioworks, HydGene Renewables and Eden Brew, the community is working on solutions for such eventualities. “Physical containment, integrated kill switches and metabolic dependencies, for instance, provide technical control…

August 11, 2022 - 6 minutesmins - By Kostas Vavitsas

In Depth 4 Jul 2022

The COVID-19 pandemic has driven RNA therapeutics into the mainstream

As messenger RNA vaccines save lives around the world, and RNA interference drugs are greenlit for rare diseases, the field of RNA therapeutics is now moving faster than ever before….

July 4, 2022 - 8 minutesmins - By Helen Albert

Persephone Bisociences Microbiome health

Startup Scout 28 Oct 2022

Persephone Biosciences studies the microbiome in baby poop

…for the treatment of the metabolic disorder hyperoxaluria. And in March 2022, the U.K. firm Microbiotica bagged £50 million ($67 million) in a Series B round to finance its own…

October 28, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 25 Jul 2022

Drug that could be the first and only in Europe to treat rare brain condition recommended for marketing authorization

…company that focuses on genetic diseases and cancers, and Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company that produces therapies for people living with rare diseases made the announcement today (July…

July 25, 2022 - 4 minutesmins - By Liza Laws

News and Trends 5 Oct 2017

Synbio adds Softness: Robots of the Future will be Squishy

…exist in nature, which therefore has a nice synergy with soft robotics. For example, genetic and metabolic circuits, two well-progressed fields of synthetic biology, could be implemented within the body…

October 5, 2017 - 5 minutesmins - By External Contributor

CatalYm’s monoclonal antibody visugromab bags $150M

News and Trends 16 Jul 2024

German biotech raises $150M on its way to tackle cancer therapy resistance

…patients through improvement of quality of life and body weight benefit. GDF-15 is not only a central regulator of immune resistance but also has a metabolic function. For instance, it…

July 16, 2024 - 9 minutesmins - By Jules Adam

Altheia Science gene therapy autoimmune disease

News and Trends 8 Apr 2020

Evotec Makes Move into Gene Therapy with Takeda Deal

…on gene therapy techniques, has expertise in virology and blood disorders, as well as metabolic and muscle diseases. Gene therapy has undergone a revolution in recent years and has changed…

April 8, 2020 - 3 minutesmins - By Helen Albert

News and Trends 22 Jun 2020

Epidarex Capital Targets UK Biotech with €112M Venture Fund

…investment is expected to be in an oncology company, and Dunlop said they also see opportunities in cardiovascular, autoimmune, metabolic and respiratory diseases. Image from Shutterstock…

June 22, 2020 - 2 minutesmins - By Laura Cowen

In Depth 2 Nov 2020

Synthetic Biology: The Next Step in the Cannabinoid Revolution

…required timeframe,” Steen noted. “[There are] so many different problems to solve: toxicity, inhibition, secretion, pathway balancing, different metabolic states in different growth stages, fermentation optimization, downstream processing…” Lipski explained….

November 2, 2020 - 6 minutesmins - By Kostas Vavitsas

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Biotech of the Week: Zealand Pharma, Biotech Success Story made in Denmark

The biggest biotech funding rounds in February 2025

14 biotech companies to know in the Boston area in 2025

Biosecurity is synthetic biology’s most crucial ally

The COVID-19 pandemic has driven RNA therapeutics into the mainstream

Persephone Biosciences studies the microbiome in baby poop

Drug that could be the first and only in Europe to treat rare brain condition recommended for marketing authorization

Synbio adds Softness: Robots of the Future will be Squishy

German biotech raises $150M on its way to tackle cancer therapy resistance

Evotec Makes Move into Gene Therapy with Takeda Deal

Epidarex Capital Targets UK Biotech with €112M Venture Fund

Synthetic Biology: The Next Step in the Cannabinoid Revolution

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!